Day 1 Welcome Address
Summer Stephan, District Attorney, San Diego County
Eric McDonald, M.D., Interim Director, Chief Medical Officer, Health and Human Service Agency, San Diego County
Luke Bergmann, Ph.D., Director, Behavioral Health Services, County of San Diego
Tara McGrath, US Attorney, US Attorney’s Office, Southern District of California
Dave King, Director, San Diego Imperial HIDTA
Carmen Rita Nevarez, MD, MPH, Co-Director, Center for Health Leadership and Impact, Public Health Institute
Keynote Catalyst
Nora Volkow, MD, Director, National Institute of Drug Abuse
National overview and the importance of models that show collaboration between justice, healthcare, and prevention sectors.
Global Health Advocacy: Turning Stories into Results
Libby Jones, Program Director, Global Health Advocacy Incubator’s Overdose Prevention Initiative
Effectively Using Advocacy to Create Change – How to best use personal experiences to move forward policy change, how to develop an effective advocacy strategy. Advocating for opioid policy change before Congress and state legislature.
Why Substance Using Behavior is Different for Youth than Adults
Kristen M. Gilliland Ph.D., Director of Outreach and Advocacy Program, Warren Center for Neuroscience Drug Discovery, Vanderbilt Medical School
What Brain Science Tells Us. Insights from Infancy to Adolescents
The Value of Prevention and Education Panel
A Division for Advancing Prevention & Treatment (ADAPT)
Lora Peppard, Ph.D., DNP, PHNNP-BC, Deputy Director for Treatment and Prevention, Washington/Baltimore HIDTA
The process of selecting appropriate and evidence-based drug education programs
San Diego County Drug Prevention Curriculum
Aimee Hendle, Drug Demand Reduction Coordinator, San Diego Imperial HIDTA
James Fontaine, JD, Chief, Major Narcotics, District Attorney’s Office, San Diego County District Attorney’s Office
Jim Crittenden, Coordinator Alcohol, Tobacco and Other Drugs, San Diego Office of Education
A local experience of selecting appropriate and evidence-based drug education programs.
Day 2 Welcome Address
Shelly Howe, DEA Special Agent in Charge, San Diego Field Division
Chauncey Parker, Deputy Commissioner, Collaborative Policing, New York Police Department
Challenges of Xylazine
Paul Wax, MD, FACMT, Executive Director, American College of Medical Toxicology
Rachel Culbreth, Ph.D., Research Director, American College of Toxicology Research Investigations Consortium, American College of Medical Toxicology
Demographics, Presentations and Drug Cross-Contamination
VA Syringe Services Program Implementation Update
Joseph Liberto, MD, Mental Health Director for Substance Abuse, Veterans Administration
Syringe services program (SSP) implementation and services available
Using Social Norms for Positive Prevention
Wesley Perkins, Ph.D., Professor of Sociology, Hobert and William Smith Colleges, New York
Importance of making the social norms approach to preventing the “reign of error” about peer substance use norms as the central aspect of prevention programs for youth and young adults.
Breakout Sessions: Prevention and Harm Reduction
Using Data to Drive Overdose Prevention
Mark Karandang, Drug Intelligence Officer/Demand Reduction Coordinator, Overdose Response Strategy/Northern CA High Intensity Drug Trafficking Area
Andy Krackov, President, Hillcrest Advisory
Data tools to better understand overdose patterns in your community and how to develop a data strategy that maximize your local work.
Moderated by Amy Max, MPH, Senior Program Manager, PHI Center for Health Leadership & Impact
Opioid Settlement Funding: What You Need to Know
Christine Minhee, J.D., Founder, OpioidSettlementTracker.com
Session will break down what is happening across the country with settlement funding, and what these funds mean for your work in overdose prevention.
Moderated by Amy Max, MPH, Senior Program Manager, PHI Center for Health Leadership & Impact
Breakout Sessions: Healthcare, Treatment, and Harm Reduction
Contingency Management and Methamphetamine
Thomas Freese, PhD, Director, Integrated Substance Abuse Programs, UCLA, Los Angeles
Contingency management and methamphetamine
Challenges and Understanding in Treatment
Lewis Nelson, M.D., MBA, Professor and Chair of the Department of Emergency Medicine and Chief of the Division of Medical Toxicology at Rutgers New Jersey Medical School, Newark, NJ
Carolyn Chu, M.D., National Clinical Consultation Center (NCCC), UCSF, San Francisco
Jesse Ristau, M.D., National Clinical Consultation Center (NCCC), UCSF, San Francisco
Listen to a variety of approaches from treatment experts.
2,859 - Will it Ever End? San Francisco’s Drug and Homeless Crisis and Overdose Epidemic
Steve Adami, MPA, Executive Director, The Way Out, The Salvation Army San Francisco
Destiny Pietsch, MPA, Salvation Army, San Francisco
Overview of San Francisco’s drug and homeless crisis
Emergency Response to Overdose and Treatment Panel
Gerard Carroll, MD, Director of EMS Fellowship, Cooper University Hospital, Camden, New Jersey
Arianna Campbell, PA-C, Co-Founder and Co-Director, CA Bridge, Oakland, California
Dennis Whitmyer, MA, Substance Use Disorder Specialist, CA Bridge, University of California, San Diego, Emergency Medicine
How emergency response to overdose is managed in different systems.
Breakout Sessions: Public Safety
State of New York Harm Reduction Strategies with a Detention Facility
Ed Fox, Project Safe Point Director, Project Safe Point, New York
Jill Harrington, Health Service Administrator, CFG Health Systems, LLC, Albany County Correctional and Rehabilitative Services Center
Program overview, including harm reduction approaches both in the facility and upon release. Value in investment and developing partnerships within the community.
Public Safety and Harm Reduction Collaboration
Jaquelyn Garcia, Agent, Overdose Response Team, Drug Enforcement Agency (DEA), Miami, FL
Program overview of fentanyl response investigations
Margaret Moore, RxStat OFR Coordinator, Drug Intelligence and Intervention Group, Office of Chief Medical Examiner (OCME) | NY/NJ High Intensity Drug Trafficking Area (HIDTA)
A response to reduce overdose deaths through cross-agency collaboration.
Treatment Behind Bars
Libby Jones, Program Director, Global Health Advocacy Incubator’s Overdose Prevention Initiative
Karl Leonard, Sheriff, Chesterfield County, Virginia
Dan Mistak, MA, MS, JD, Acting President and Director of Health Care Initiatives for Justice-Involved Populations, Community Oriented Correctional Health Services.
Improving public health and public safety by providing treatment in a carceral setting
Successful Law Approaches
Adam Gordon, Assistant United States Attorney, US Attorney’s Office
Matthew Schick, Supervisory Special Agent, Homeland Security Investigations
Christoffer Lee, Assistant United States Attorney, Northern District of California
Innovative multi-agency collaborations that are combatting the fentanyl crisis
Innovative Campaign – #Blocking Fentanyl on College Campuses
Adam Gordon, Assistant United States Attorney, US Attorney’s Office
Dylan Aste, Assistant United States Attorney, US Attorney’s Office
Mark Robertson, San Diego City Attorney’s Office
Successful fentanyl on media campaign on college campuses